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Basic Investigations 
Synergetic Effect of Yihuo Qingyi Decoction (Ⲟ⌏ޞ㛄∸) and 
Recombinant Staphylokinase in Treatment of Severe Acute Pancreatitis 
of Rats 
CHEN Yong-feng 䰜∌ዄ 1, SHA Jian-ping ≭ᓎᑇ 2, and WU Zhong-min ਈӆᬣ 1
Objective: To investigate the effect of recombinant staphylokinase (r-Sak) and the Chinese medicine Yihuo Qingyi 
Decoction (Herbal decoction for severe acute pancreatitis) in the treatment of the severe acute pancreatitis (SAP) in 
rats, and to observe the synergistic effect of the two. Methods: One hundred and sixty-two adult male SD rats with 
the body mass of 250–280 g were randomly divided into the following 5 groups: sham operation group (n=18), 
control group (n=36), Yihuo Qingyi Decoction treatment group (n=36), r-Sak treatment group (n=36), and Yihuo 
Qingyi Decoction plus r-Sak treatment group (n=36). The SAP ratmodel was prepared by retrograde injection of 5% 
sodium taurocholate into the cholangiopancreatic duct. Two days before modeling, Yihuo Qingyi Decoction was 
intragastrically administrated, and r-Sak was intraperitoneally injected. The survival rate within 18 h after modeling 
was determined. The pancreatic blood flow, the weight of ascites, and the serum amylase and lipase were 
investigated at 6 h, 12 h, and 18kh after modeling, and the pancreatic tissue was examined under light microscopy 
to see its pathological change. Results: The 18 h survival count of group A,B,C,D and E rats was 9,2,6,7 and 8 
respectively. After r-Sak and Yihuo Qingyi Decoction intervention, the serum amylase and lipase and the weight of 
ascites were significantly decreased, especially in group E.18 h after modeling, the level of the serum amylase and 
lipase and the weight of ascites in group E was 1 100±118 U·L-1,1 000±150 U·L-1 and 13.40±1.80 g respectively, 
obviously lower than that of group B (P<0.05).After SAP was induced, the pancreatic blood flow showed a 
tendency to decrease, but the decrease extent in the treatment groups was smaller than that in the control group.18h 
after modeling, the pancreatic blood flow in group B and group E was 30.16±8.96 mL·100 g-1·min-1,and 
129.10±42.58 mL·100 g-1·min-1 respectively, there was significant difference (P<0.05). The pathological change of 
the pancreatic tissue was alleviated in the treatment groups. Conclusion: Both r-Sak and Yihuo Qingyi Decoction 
play a beneficial role in the treatment of rat SAP and there is a synergistic effect between the two. 
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The definite pathogenesis of severe acute pancreatitis 
(SAP) is still not clear, and the effect of conventional 
treatments is not satisfactory enough. In recent years, the 
studies showed that the pathological change of pancreatic 
microcirculation plays an important role in attack of 
acute pancreatitis. Local disorder of pancreatic micro- 
circulation, microvascular thrombosis, and blood flow 
blockage can cause acute pancreatitis.1-3 The pancreatic 
ischemia is believed to be possibly the key factor causing 
hemorrhage, necrosis, and autolysis of the pancreatic 
tissue in pancreatitis of acute necrotic type.4-7 Based on 
the studies of pathogenesis of acute pancreatitis, the 
authors propose a new thinking for treatment of SAP 
with specific thrombolytic agents. In this study, the effect 
of recombinant staphylokinase (r-Sak) and Yihuo Qingyi 
Decoction (Ⲟ⌏ޞ㛄∸ Herbal decoction for severe 
acute pancreatitis) on SAP of rats and the synergistic 
effect between the two were investigated in the hope of 
providing experimental evidence for treatment of SAP 
with TCM and western medicine in combination. 
MATERIALS AND METHODS 
Animals  
One hundred and sixty-two adult male SD rats with the 
body mass of 250–280 g were provided by the 
Experimental Animal Center of Chengdu University of 
Traditional Chinese Medicine.Clean grade,animal 
experiment licence: SCXK (CHUAN) 2006-11.  
Drugs and Reagents1
Standard r-Sak was provided by China National Institute 
for the Control of Pharmaceutical and Biological 
Products. 45% sodium taurocholate (STC) was 
purchased from Sigma Company, USA. Yihuo Qingyi 
Decoction composed of Dai Huang (Radix et Rhizoma 
Rhei) 50 g (decocted later), Mang Xiao (Natrii Sulphas) 
50 g, Huang Qin (Radia Scutellariae) 15 g, Bai Shao
(Radia Paeoniae Alba) 15 g, Mai Dong (Radix 
Ophiopogonis) 15g, Mu Xiang (Radix Aucklandiae) 9 g, 
Chai Hu (Radix Bupleuri) 12 g, Bing Lang (Semen 
Arecae) 12 g, Ku Lian Pi (Cortex Meliae) 10 g, Shi Jun 
Zi (Fructus Quisqualis) 12 g, Chuan Xiong (Rhizoma 
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Chuanxiong) 12 g, Dan Shen (Salviae Miltiorrhizae) 15 g, 
Huang Qi (Radix Astragali) 15gg, and Ren Shen (Radix 
Ginseng) 10 g was decocted in water into a 100% 
decoction containing crude ingredient of 1 g/mL. 
Modeling and Grouping of Animals 
The SD rats were randomly divided into the following 5 
groups: sham operation group (group A, n=18), control 
group (group B, n=36), Yihuo Qingyi Decoction 
treatment group (group C, n=36), r-Sak treatment group 
(group D, n=36), and Yihuo Qingyi Decoction plus r-Sak 
treatment group (group E, n=36). The rats fasted for 12 h 
but were freely access to water before experiment. 
The rats were anaesthetized with intraperitoneal injection 
of 3% pentobarbital sodium (35 mg/kg). After a 
conventional disinfection and towel spreading, an 
incision along the white line of abdomen was conducted, 
and the retrograde pressurizing injection of 5% sodium 
taurocholate solution through the cholangiopancreatic 
duct (1.5 mL/kg) was adopted. About 10 min later, 
swelling and petechial hemorrhagic necrosis appeared in 
the pancreas in the rats of group B and C. In group A, 
only the pancreas was turned. In group C, 2 days before 
modeling, Yihuo Qingyi Decoction was intragastrically 
administrated, twice a day, 2 g each time. In group D, 2 
days before modeling, r-Sak was administrated by 
intraperitoneal injection, 1.5 mg/kg, twice daily. In group 
E, 2 days before modeling, intragastric administration of 
Yihuo Qingyi Decoction (twice/d, 2 g/time) and 
intraperitoneal injection of r-Sak (1.5 mg/kg, twice/d) 
were carried out. In group B, equal volume of 0.85% 
NaCl was given by intragastrical administration. And no 
drug was given in group A. After modeling, both 
intragastrical administration and intraperitoneal injection 
were continuously performed until the rats were killed. 
Nine rats were randomly selected from each group for 
determining the survival rate within 18 h after modeling. 
Nine rats were killed by decapitation at 6 h, 12 h, and 18 
h after modeling, and the arterial blood and pancreatic 
tissue were collected.  
Determination of Serum Amylase and Lipase  
Serum amylase and lipase were detected by a Hitachi 
7170A full-automatic biochemical analyzer.  
Detection of Ascites Weight 
After the rats were killed and the abdomen was open, dry 
gauze was placed into the abdominal cavity to absorb the 
ascites. The weight difference between the wet gauze and 
the dry gauze was regarded as ascites weight. 
Measurement of Pancreatic Blood Flow  
Intraperitoneal anesthesia (3% pentobarbital sodium, 30 
mg/kg), conventional disinfection, towel spreading, and 
abdominal incision were performed at 6 h, 12 h, and 18 h 
after modeling respectively. After the abdomen was 
incised, the electrolytic electrode of LS III tissue blood 
flow meter was penetrated into the cavity 1.0 cm towards 
the right posterior upper part from the spleen side end of 
pancreas. Twenty minutes later the measurement started 
and the values were recorded in an interval of 10 min. 
The tissue blood flow meter was automatically balanced 
and traced by a computer. The data was calculated and 
showed automatically by RCBF Bench software. 
Pathological Examination 
Pathological examination of pancreas was performed 
with the conventional method. The pancreatic tissue was 
stained with HE and examined under a light microscopy. 
Statistical Analysis 
All data were expressed as mean ± standard deviation 
( xfs) and the t-test and Ȥ2 test were used for statistics. 
The data was analyzed by using SPSS computer software 
Version 6.0. Level of significance was fixed at 0.05. 
RESULTS 
Survival Rats within 18h after Modeling 
In group A, B, C, D and E, 9, 2, 6, 7, and 8 rats survived 
respectively. 
Pathological Change of Pancreas and Myocardium 
The obvious pathological change of pancreas was not 
found in group A, but the hemorrhagic necrosis, mostly 
the coagulative necrosis, appeared in group B with the 
isolated island-like distribution of the acinus. In group C, 
D and E, the pathological change was significantly 
alleviated, the pancreatic cells had mild degeneration and 
edema with the interstitial vasodilatation and hyperemia, 
the interlobular septum widened, and a small amount of 
fat had necrosis. The myocardial tissue in group A had no 
significant pathological change. In group B, the 
myocardial cells had the swelling with spotty and 
piecemeal necrosis which connected each other into 
pieces sometimes, and there was infiltration of 
inflammatory cells and formation of cell contraction 
band. The myocardial cells in group C, D and E had a 
mild swelling, the cross striations were clear, no 
myocardial necrosis focus was found, the arrangement 
and structure of the myocardial cell were basically 
normal, and there was a small amount of inflammatory 
cell infiltration. 
Changes of Amylase, Lipase, and Weight of Ascites 
At each time point, the amylase and lipase and the 
weight of ascites in group A, C, D and E significantly 
decreased as compared with group B (P<0. 05), those in 
group C decreased as compared with group D (P<0. 05), 
and those in group E decreased as compared with group 
C and D (P<0.05), as shown in Table 1. 
Change of Pancreatic Blood Flow 
The pancreatic blood flow in all groups showed a 
tendency to decrease after SAP was induced, especially 
in group B. The pancreatic blood flow in group B 
significantly decreased as compared with group A at 6h, 
12 h, and 18 h after modeling (P<0.05). The pancreatic 
blood flow in group C, D and E was also significantly 
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decreased (P<0.05), but the decrease extent was smaller 
than in group B, in group D was smaller than in group C, 
and in group E was the smallest, as showed in Figure 1. 
Table 1. Effect of r-Sak and Yihuo Qingyi Decoction on serum amylase and lipase and weight of ascites in SAP rats  
( xfs, n=9) 
Group Time points (h) Amylase/(U·L-1) Lipase/(U·L-1) Weight of ascites (g) 
A    520±105 2,000±300 0.25±0.01 
B 6 11,000±500a  8,080±800a 12.70±3.00a
 12 14,000±460a  8,500±500a 14.50±4.00a
 18 12,000±345a  8,000±470a 16.80±3.20a
C 6   4,500±210abd   2,700±200abd    7.50±1.20abd
 12   4,000±150abd   2,800±190abd    8.80±1.10abd
 18   2,800±170abd   2,500±140abd   10.90±1.30abd
D 6  4,800±180ab  3,500±300ab  10.50±1.40ab
 12  4,500±130ab  3,200±170ab  11.20±1.30ab
 18  3,500±120ab  3,000±120ab  13.40±1.80ab
E 6   2,700±110abcd  1,140±88abcd    5.00±2.00abcd
 12   1,200±120abcd   1,400±210abcd    6.20±2.50abcd
 18   1,100±118abcd   1,000±150abcd  13.40±1.80ab
Notes: a. P<0.05, compared with group A; b. P<0.05, compared with group B; c. P<0.05, compared with group C; d. P<0.05, compared  
with group D. 
Figure 1. Effect of r-Sak and Yihuo Qingyi Decoction on the pancreatic blood flow in SAP rats 
DISCUSSION 
The recombinant Sak is a very effective thrombolytic 
agent with fibrin specificity. Because it does not activate 
the systematic fibrinolysis, with only few side effects but 
high thrombolytic activity (especially the arterial 
thrombosis containing rich blood platelet), it is believed 
to be one of the most promising thrombolytic drugs. At 
present, in the treatment of myocardial infarction, 
cerebral thrombosis, and thrombotic diseases with r-Sak, 
more studies on its effect on the blood flow of coronary 
artery and cerebral artery have been carried out.8-11
However, any report on r-Sak for treatment of 
pancreatitis as well as its effect on blood flow of 
pancreatic tissue has not been found yet. In the very 
study, the therapeutic effect of r-Sak on SAP as well as 
its influence on blood flow of pancreatic tissue were 
studied for the first time.  
Treatment of SAP with TCM and western medicine in 
combination has a long history in China. Qingyi 
Decoction (⏙㛄∸ Decoction for acute pancreatitis), 
composed of the Chinese herbs with functions of 
promoting blood circulation and supplementing qi, 
clearing heat and toxic material, and purgation, is proved 
to be the effective prescription for AP in clinic.12-15 The 
Chinese herbs with the effect of promoting blood 
circulation to relieve blood stasis can improve the 
microcirculation dysfunction and stabilize the function of 
cell membrane in SAP, which have attracted a great 
attention.16-18 In the Yihuo Qingyi Decoction used in this 
experiment, Ren Shen, Mai Dong and Huang Qi to 
supplement qi and nourish yin, and Chuan Xiong and 
Dan Shen to promote blood circulation and remove 
blood stasis were added to the traditional Qingyi 
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Decoction for the purpose to increase the effect of 
promoting blood circulation to remove blood stasis.
The result of this study shows that the single use of r-Sak 
or Yihuo Qingyi Decoction can significantly improve the 
pathological state in serum enzyme, ascites, and blood 
flow of pancreatic tissue, indicating that either of them 
has therapeutic effect on rat SAP. In the present study, it 
is proved that r-Sak is stronger in improving ischemia of 
pancreatic tissue, while Yihuo Qingyi Decoction is better 
in decreasing serum enzyme and relieving ascites. Their 
combination is more effective in improving all the above 
indices, indicating that Yihuo Qingyi Decoction and 
r-Sak have a synergistic action in treatment of SAP, 
although the mechanism needs to be further explored. 
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